Fundsmith LLP’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $824M | Sell |
1,465,786
-410,249
| -22% | -$263M | 6.42% | 7 |
|
|
2025
Q4 | $1.27B | Sell |
1,876,035
-734,422
| -28% | -$500M | 7.42% | 3 |
|
|
2025
Q3 | $1.67B | Sell |
2,610,457
-28,832
| -1% | -$17.5M | 8.43% | 2 |
|
|
2025
Q2 | $1.42B | Sell |
2,639,289
-9,042
| -0.3% | -$4.32M | 6.15% | 5 |
|
|
2025
Q1 | $1.11B | Sell |
2,648,331
-14,524
| -0.5% | -$6.31M | 5.06% | 8 |
|
|
2024
Q4 | $1.1B | Sell |
2,662,855
-1,307
| -0% | -$573K | 4.69% | 10 |
|
|
2024
Q3 | $1.35B | Buy |
2,664,162
+970
| +0% | +$471K | 5.32% | 7 |
|
|
2024
Q2 | $1.3B | Sell |
2,663,192
-51,570
| -2% | -$25.9M | 5.29% | 7 |
|
|
2024
Q1 | $1.47B | Sell |
2,714,762
-14,155
| -0.5% | -$7.74M | 5.74% | 5 |
|
|
2023
Q4 | $1.51B | Sell |
2,728,917
-235,637
| -8% | -$111M | 6.34% | 4 |
|
|
2023
Q3 | $1.3B | Buy |
2,964,554
+3,003
| +0.1% | +$1.5M | 5.89% | 7 |
|
|
2023
Q2 | $1.49B | Buy |
2,961,551
+7,355
| +0.2% | +$3.52M | 6.24% | 5 |
|
|
2023
Q1 | $1.48B | Sell |
2,954,196
-489,536
| -14% | -$234M | 6.37% | 4 |
|
|
2022
Q4 | $1.4B | Sell |
3,443,732
-177,045
| -5% | -$68.7M | 6.42% | 4 |
|
|
2022
Q3 | $1.18B | Buy |
3,620,777
+1,902
| +0.1% | +$699K | 5.6% | 5 |
|
|
2022
Q2 | $1.27B | Buy |
3,618,875
+813
| +0% | +$332K | 5.6% | 5 |
|
|
2022
Q1 | $1.98B | Sell |
3,618,062
-624,221
| -15% | -$328M | 6.8% | 2 |
|
|
2021
Q4 | $2.79B | Buy |
4,242,283
+81
| +0% | +$50.8K | 6.82% | 2 |
|
|
2021
Q3 | $2.64B | Sell |
4,242,202
-260
| -0% | -$175K | 7.29% | 3 |
|
|
2021
Q2 | $2.68B | Buy |
4,242,462
+21,850
| +0.5% | +$12.1M | 7.42% | 3 |
|
|
2021
Q1 | $2.07B | Sell |
4,220,612
-5,816
| -0.1% | -$2.91M | 6.57% | 3 |
|
|
2020
Q4 | $2.11B | Sell |
4,226,428
-6,387
| -0.2% | -$2.86M | 7% | 3 |
|
|
2020
Q3 | $1.66B | Sell |
4,232,815
-7,896
| -0.2% | -$2.92M | 6.5% | 4 |
|
|
2020
Q2 | $1.4B | Sell |
4,240,711
-4,516
| -0.1% | -$1.31M | 6.11% | 4 |
|
|
2020
Q1 | $1.03B | Sell |
4,245,227
-346,672
| -8% | -$90.5M | 5.79% | 6 |
|
|
2019
Q4 | $1.2B | Buy |
4,591,899
+35,883
| +0.8% | +$9.46M | 5.67% | 10 |
|
|
2019
Q3 | $1.24B | Buy |
4,556,016
+85,978
| +2% | +$23.9M | 6.33% | 7 |
|
|
2019
Q2 | $1.23B | Buy |
4,470,038
+2,697
| +0.1% | +$665K | 6.41% | 4 |
|
|
2019
Q1 | $999M | Buy |
4,467,341
+35,049
| +0.8% | +$7.24M | 5.68% | 10 |
|
|
2018
Q4 | $1.11B | Buy |
4,432,292
+5,649
| +0.1% | +$1.16M | 7.03% | 3 |
|
|
2018
Q3 | $1.11B | Sell |
4,426,643
-2,461
| -0.1% | -$597K | 7.41% | 3 |
|
|
2018
Q2 | $965M | Buy |
4,429,104
+1,447
| +0% | +$298K | 7.18% | 4 |
|
|
2018
Q1 | $847M | Buy |
4,427,657
+22,901
| +0.5% | +$4.23M | 6.99% | 6 |
|
|
2017
Q4 | $689M | Sell |
4,404,756
-14,088,162
| -76% | -$2.22B | 5.9% | 9 |
|
|
2017
Q3 | $1.58B | Buy |
18,492,918
+14,046,878
| +316% | +$2.22B | 15.34% | 1 |
|
|
2017
Q2 | $718M | Sell |
4,446,040
-34,167
| -0.8% | -$5.55M | 7.53% | 5 |
|
|
2017
Q1 | $693M | Buy |
4,480,207
+3,341
| +0.1% | +$461K | 8.05% | 1 |
|
|
2016
Q4 | $529M | Sell |
4,476,866
-14,017
| -0.3% | -$1.6M | 6.96% | 4 |
|
|
2016
Q3 | $506M | Buy |
4,490,883
+21,547
| +0.5% | +$2.27M | 6.92% | 3 |
|
|
2016
Q2 | $415M | Buy |
4,469,336
+258,657
| +6% | +$22.2M | 6.57% | 7 |
|
|
2016
Q1 | $330M | Buy |
4,210,679
+1,719,511
| +69% | +$124M | 7.1% | 5 |
|
|
2015
Q4 | $182M | Buy |
2,491,168
+1,610,682
| +183% | +$115M | 4.56% | 12 |
|
|
2015
Q3 | $65.4M | Buy |
880,486
+813,646
| +1,217% | +$58.3M | 1.99% | 16 |
|
|
2015
Q2 | $4.29M | Buy |
66,840
+15,854
| +31% | +$1.1M | 0.13% | 18 |
|
|
2015
Q1 | $3.94M | Buy |
+50,986
| New | +$3.97M | 0.13% | 19 |
|
Other funds holding IDXX
VCM
VPM
Fundsmith LLP's IDXX Position: Q1 2026 in Review
Fundsmith LLP reduced its Idexx Laboratories (IDXX) stake by 22% in Q1 2026, selling an estimated $263M and leaving 1,465,786 shares worth $824M. The position accounts for 6.42% of the portfolio, ranked #7.
Fundsmith LLP first reported a position in IDXX in Q1 2015 and has held it in 45 quarters since. The position peaked at $2.79B in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Fundsmith LLP held 1,465,786 shares of Idexx Laboratories worth $824M as of Q1 2026.
- Fundsmith LLP sold 410,249 Idexx Laboratories shares in Q1 2026, an estimated $263M.
- Idexx Laboratories made up 6.42% of Fundsmith LLP's portfolio in Q1 2026, its #7 holding.
- Fundsmith LLP first reported a position in Idexx Laboratories in Q1 2015 and has held it in 45 quarters since.
- Fundsmith LLP's Idexx Laboratories position peaked at $2.79B in Q4 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Fundsmith LLP's 13F filing for Q1 2026, filed 15 May 2026.